Security Snapshot

Caris Life Sciences, Inc. - COMMON STOCK (CAI) Institutional Ownership

CUSIP: 142152107

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

254

Shares (Excl. Options)

74.53MFull value: 74,526,412 · shares · 30 Sep 2026

Price

$30.63

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.02%
Share change
-28,506,773
Value change
-$636,139,610
Number of holders
254
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
282,054,602
SEC-reported price per share
$31.11
Insider filing price
$31.11
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • CAI - Caris Life Sciences, Inc. - COMMON STOCK is tracked under CUSIP 142152107.
  • 254 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 248 to 254 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $2.75BFull value: $2,752,410,768 · USD · 30 Jun 2026
    to
    $2.28BFull value: $2,282,965,664 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 254 institutions filings for Q3 2026.

Open SEC evidence

Security key

142152107

13F reference period

Q3 2026

13F holders

254

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
CAI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HALBERT DAVID D 44% $3,311,265,907 124,906,296 David D. Halbert 30 Jun 2025
FMR LLC 13% +24% $1,122,142,952 +$212,691,203 37,795,317 +23% FMR LLC 30 Sep 2026
J H Whitney VI L P 4% -36% $211,061,531 -$131,250,000 11,256,615 -38% J H Whitney VI L P 30 Jun 2026
TSSP Sub-Fund HoldCo LLC 2.6% -50% $137,382,019 -$132,344,212 7,327,041 -49% Alan Waxman 30 Jun 2026
RIVERVIEW GROUP LLC 1.3% 3,583,100 Millennium Management LLC 17 Jun 2025
As of 30 Sep 2026, 254 institutional investors reported holding
74.53MFull value: 74,526,412 · shares · 30 Sep 2026
shares of Caris Life Sciences, Inc. - COMMON STOCK (CAI). This represents 26% of the company’s total
282.05MFull value: 282,054,602 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
17%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 2% 5,733,874 0% $175,628,561
VANGUARD PORTFOLIO MANAGEMENT LLC 1.7% 4,729,952 0.01% $144,878,430
Capital World Investors 1.6% 4,389,442 0.02% $134,448,608
Sixth Street Partners Management Company, L.P. 1.1% 3,032,770 19% $92,893,745
LOS ANGELES CAPITAL MANAGEMENT LLC 1.1% 2,963,805 0.31% $90,781,346
BRAIDWELL LP 0.97% 2,746,688 3.5% $84,131,053
GEODE CAPITAL MANAGEMENT, LLC 0.85% 2,391,343 0% $73,271,358
ORBIMED ADVISORS LLC 0.78% 2,192,911 1.2% $67,168,864
MAK CAPITAL ONE LLC 0.76% 2,152,433 11% $65,929,023
STATE STREET CORP 0.76% 2,138,955 0% $65,516,192
J. H. Whitney Equity Partners VI, LLC 0.62% 1,750,615 100% $53,621,337
FIL Ltd 0.56% 1,583,262 0.03% $48,495,315
CANADA PENSION PLAN INVESTMENT BOARD 0.44% 1,243,514 0.02% $38,088,834
FEDERATED HERMES, INC. 0.43% 1,202,131 0.05% $36,821,273
PANAGORA ASSET MANAGEMENT INC 0.38% 1,061,668 0.1% $32,518,891
Champlain Investment Partners, LLC 0.37% 1,053,960 1.1% $32,282,795
BANK OF AMERICA CORP /DE/ 0.34% 968,306 0% $29,659,213
VANGUARD FIDUCIARY TRUST CO 0.29% 820,060 0.01% $25,118,438
GOLDMAN SACHS GROUP INC 0.29% 808,666 0% $24,769,439
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.28% 792,352 0.01% $24,269,742
WORLDQUANT MILLENNIUM ADVISORS LLC 0.27% 761,420 0.07% $23,322,295
Woodline Partners LP 0.26% 723,163 0.07% $22,150,483
RENAISSANCE TECHNOLOGIES LLC 0.23% 656,500 0.03% $20,108,595
Jump Financial, LLC 0.22% 632,119 0.15% $19,361,805
TWO SIGMA INVESTMENTS, LP 0.2% 558,872 0.01% $17,118,249

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
6
Headline period
Q3 2026
Rows shown
1-6 of 6
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 74,526,412 $2,282,965,664 -$636,139,610 $30.63 254
2026 Q2 154,262,946 $2,752,410,768 -$56,423,201 $17.82 248
2026 Q1 156,665,947 $2,797,623,495 -$13,711,338 $17.88 200
2025 Q4 145,171,924 $3,916,731,528 +$281,575,305 $26.98 184
2025 Q3 113,389,372 $3,407,348,453 +$143,025,542 $30.25 137
2025 Q2 109,280,872 $2,919,429,193 +$2,917,131,273 $26.72 115
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .